Ep. 520 Frontiers in Musculoskeletal Embolization with Dr. Yuji Okuno
Musculoskeletal embolization is generating significant excitement in the field of chronic pain management. In this episode, Dr. Jacob Fleming hosts a discussion with Dr. Yuji Okuno from Japan, a pione...
25 Feb 202538min
Ep. 519 Transplantation for HCC: Who, When, and How?
The process of liver transplantation involves many complexities, and each patient's path to transplant is unique. To offer insider perspectives on this process, Dr. Zachary Berman sits down with trans...
21 Feb 202545min
Ep. 518 Long-Term Outcomes of Prostatic Artery Embolization (PAE) with Dr. Shivank Bhatia
Do we finally have definitive data on the efficacy of prostate artery embolization (PAE)? Dr. Shivank Bhatia (interventional radiologist at University of Miami) joins host Dr. Michael Barraza to discu...
18 Feb 202554min
Ep. 517 Complex HCC Patients and the "Grey Zone": What to Do When You Don’t Know What to Do
Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to palliative intent. To explore the "grey zone" of treatment goals for intermediate-stage ...
14 Feb 202539min
Ep. 516 Dialysis Procedures: New Tools for Better Outcomes with Dr. Ari Kramer and Dr. Omar Davis
Given the challenges that our dialysis patients face, how can we as providers stay sharp with the latest access techniques to help ensure the best possible outcomes? Dr. Omar Davis (interventional nep...
11 Feb 20251h 12min
Ep. 515 Curative Intent Therapies for HCC: Today and Tomorrow
For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation can be a curative treatment. With multiple ablation options available and still un...
7 Feb 202552min
Ep. 514 Deep Sedation in IR: Intro to Ketamine with Dr. Amy Deipolyi
When deep sedation is required, it can be challenging to implement due to the difficulty of scheduling dedicated anesthesia coverage in the IR suite. Dr. Amy Deipolyi (interventional radiologist and D...
4 Feb 202533min
Ep. 513 Combination Therapy and Clinical trials for Advanced HCC: What They Really Mean
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors and chemotherapy, making it an exciting time to be...
31 Jan 202547min
